An Introduction to Virtual Clinical Trials [Video]

Learn what virtual clinical trials are, when they make sense, and how to design them without compromising safety, oversight, or data quality.

In this explainer, we outline the spectrum from hybrid models—where activities like eConsent, tele-visits, and couriered samples move off-site—to near-virtual designs with home assessments and direct-to-patient drug supply. You’ll hear the latest regulatory expectations across the US, EU, and UK, how to protect data integrity with validated systems and audit trails, and why PI oversight remains central even in decentralised models. We also cover practical safeguards for drug supply, identity checks, and monitoring, plus the inclusion measures that help trials avoid digital barriers and reach broader populations.

At Quanticate, our biometrics teams support sponsors in planning and running virtual trials end to end: from risk assessments and data-flow mapping to centralised monitoring, technology selection, and contingency planning. With expertise in data management, statistics, and regulatory compliance, we help sponsors use decentralisation wisely while maintaining trial integrity. Submit an RFI today.